[A case of anti-myelin oligodendrocyte glycoprotein antibody-positive multiphasic disseminated encephalomyelitis showing significant recovery after immunoadsorption plasmapheresis]

Rinsho Shinkeigaku. 2023 Aug 29;63(8):518-522. doi: 10.5692/clinicalneurol.cn-001868. Epub 2023 Jul 29.
[Article in Japanese]

Abstract

The patient is an 18-year-old female. She had a history of acute disseminated encephalomyelitis at the age of 6 and 7. She visited our hospital due to acute disturbance of consciousness, quadriplegia, and numbness of left upper and lower extremities. Brain MRI showed multiple DWI/FLAIR high-signal lesions in the bilateral cerebral hemispheres, cerebellum, and brainstem. Qualitative test indicated that serum anti-MOG antibodies was positive, and she was diagnosed with anti-MOG antibody-positive polyphasic disseminated encephalomyelitis. Intravenous mPSL pulse therapy was performed twice, but the symptoms worsened. As a second line treatment, plasma exchange was started. However, she developed transfusion related acute lung injury. Alternatively, she was treated with immunoadsorption plasmapheresis. Her symptoms were significantly improved. This case seems to be valuable because there are few reports showing effectiveness of immunoadsorption therapy on anti-MOG antibody-related diseases, especially for polyphasic disseminated encephalomyelitis.

Keywords: acute disseminated encephalomyelitis (ADEM); anti-myelin oligodendrocyte glycoprotein antibody (MOG antibody); apheresis; immunoadsorption plasmapheresis; multiphasic disseminated encephalomyelitis (MDEM).

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Autoantibodies
  • Encephalomyelitis, Acute Disseminated* / diagnosis
  • Encephalomyelitis, Acute Disseminated* / etiology
  • Encephalomyelitis, Acute Disseminated* / therapy
  • Female
  • Humans
  • Myelin-Oligodendrocyte Glycoprotein
  • Oligodendroglia
  • Plasmapheresis / adverse effects

Substances

  • Autoantibodies
  • Myelin-Oligodendrocyte Glycoprotein